Home > Insider Trading > Filing (0001192482-18-000260)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1267565	Collegium Pharmaceutical Inc	COLL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1443841	Joseph Ciaffoni	C/O Collegium Pharmaceutical, Inc. 780 Dedham Street, Suite 800 Canton MA 02021	Chief Operating Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-05-31	64,821	$8.22	174,089	No	4	M	Direct
Common Stock	Disposition	2018-05-31	59,204	$22.54	114,885	No	4	S	Direct
Common Stock	Disposition	2018-05-31	5,617	$23.35	109,268	No	4	S	Direct
Common Stock	Disposition	2018-05-31	6,205	$22.62	103,063	No	4	F	Direct
Common Stock	Disposition	2018-06-01	14,862	$22.48	88,201	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock option (right to purchase)	Disposition	2018-05-31	64,821	$0.00	64,821	$8.22

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
194,462		2027-05-31	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2017.
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.10 to $23.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (5).
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.10 to $23.45, inclusive.
Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.14 to $22.91, inclusive.
64,821 shares subject to the option vested and became exercisable on May 31, 2018. The remaining 194,462 shares subject to the option vest in equal quarterly installments (rounded up to the nearest whole share of common stock) over a three year period, subject to the reporting person's continued service with the issuer.